/
INNPF
$1.70-$0.20 (-10.53%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$1.70 – $14.26
0% from low
Exchange
OTC Link
OS
Borrow rate
3.70%
Moderate
Price (6 mo)
Loading chart…
Change$-38.98
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $8.0K | $196.0K | $2.6M | $13.7M | $29.4M | $26.6M |
| Cost of revenue | $0 | $23.5K | $5.0K | $75.0K | $452.0K | $1.7M | $3.3M | $2.7M |
| Gross profit | $0 | −$23.5K | $3.0K | $121.0K | $2.1M | $12.0M | $26.2M | $23.9M |
| Gross margin | — | — | 37.5% | 61.7% | 82.3% | 87.7% | 89.0% | 89.9% |
| R&D | $534.0K | $368.0K | $1.4M | $1.4M | $1.5M | $1.8M | $1.5M | $932.0K |
| Operating income | −$1.2M | −$3.0M | −$4.7M | −$7.5M | −$6.3M | $3.8M | −$1.2M | −$1.3M |
| EBITDA | $0 | −$3.0M | −$4.9M | −$7.4M | −$3.7M | −$3.8M | −$1.2M | $130.0K |
| Net income | −$1.2M | −$3.3M | −$10.0M | −$10.0M | −$3.8M | −$4.7M | −$1.8M | −$1.1M |
| Net margin | — | — | -124412.5% | -5126.0% | -147.1% | -34.4% | -6.2% | -4.2% |
| EPS (diluted) | -0.54 | -1.51 | -3.99 | -2.91 | -0.98 | -1.19 | -0.42 | -0.25 |
Annual figures · source: Financial Modeling Prep
Peer comparison
INNOCAN PHARMA CORP
INNOCAN PHARMA CORP
Held by traders on TradeandTell
No one on the platform currently holds INNPF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in INNPF as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2025-09-05 | 1-for-65reverse |
Recent trades on TradeandTell
No one on the platform has traded INNPF yet.
